Lumi Global Acquires Assembly Voting to Strengthen Product Leadership and Accelerate International Expansion 20-12-2024, 01:36

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound 9-07-2024, 07:00

GMAC Board Election Affirms Continuity, Drive toward Business for Good 17-07-2024, 20:00